With growing demands, managing pharmaceutical workflows have become more complex.
Researching and testing new drugs is now loaded with inefficiencies, from compliance issues to missing deadlines.
Pharma competences & processes geared to risk minimization at expense of speed & flexibility
is an expensive and all too real issue looming over pharmaceutical companies across the globe.
big drugmakers spend more than $2.5 billion to get a new medicine to patients.
Just one of every 10 therapies that enters human clinical trials makes it to the pharmacy, and one of 10-15k from Discovery
In the 20 years since the human genome was sequenced, researchers have found treatments for a tiny fraction of the 7,000 known rare diseases.